Liquid formulations of salts of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl ] piperazine
Details for Australian Patent Application No. 2010238946 (hide)
International Classifications
Event Publications
1 December 2011 Amendment Made
The nature of the amendment is: Amend the priority details to read PA 200900531 24 Apr 2009 DK 2010239266 Resverlogix Corp. The nature of the amendment is as shown in the statement(s) filed 31 Oct 2011
8 December 2011 PCT application entered the National Phase
PCT publication WO2010/121621 Priority application(s): WO2010/121621
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2010238985-Novel 7-deazapurine nucleosides for therapeutic uses
2010238945-Particulate material for controlled release of active ingredients
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser